Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Ma, Ying ^a   Ma, Lin ^a   Guo, Quan ^a   Zhang, Shulan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BMP2 PROTEIN, HUMAN; BMPR1A PROTEIN, HUMAN; BMPR1B PROTEIN, HUMAN; BMPR2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; MESSENGER RNA;

ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADULT; AGED; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; MIDDLE AGED; NEOPLASM; OVARY; OVARY TUMOR; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; YOUNG ADULT;

EID: 77954049626     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-85     Document Type: Article

References (23)

1. Isolation and characterization of a novel human NM23-H1B gene, a different transcript of NM23-H1. X Ni S Gu J Dai H Cheng L Guo L Li C Ji Y Xie K Ying Y Mao, J Hum Genet 2003 48 2 96 100 10.1007/s100380300014 12601555 (Pubitemid 36305863)
2. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. JM Wozney, Eur J Oral Sci 1998 106 Suppl 1 160 166 9541220
3. Divergence and convergence of TGF-beta/BMP signaling. K Miyazono K Kusanagi H Inoue, J Cell Physiol 2001 187 3 265 276 10.1002/jcp.1080 11319750
4. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. N Ghosh-Choudhury G Ghosh-Choudhury A Celeste PM Ghosh M Moyer SL Abboud J Kreisberg, Biochim Biophys Acta 2000 1497 2 186 196 10.1016/S0167-4889(00)00060-4 10903423
5. A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells. N Dumont CL Arteaga, Biochem Biophys Res Commun 2003 301 1 108 112 10.1016/S0006-291X(02)02977-7 12535648
6. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. N Ghosh-Choudhury K Woodruff W Qi A Celeste SL Abboud G Ghosh Choudhury, Biochem Biophys Res Commun 2000 272 3 705 711 10.1006/bbrc.2000.2844 10860819
7. Bone morphogenetic protein 2 suppresses the transformed phenotype and restores actin microfilaments of human lung carcinoma A549 cells. A Tada T Nishihara H Kato, Oncol Rep 1998 5 5 1137 1140 9683824
8. Expression of bone morphogenetic proteins in human lung carcinomas. EM Langenfeld J Bojnowski J Perone J Langenfeld, Ann Thorac Surg 2005 80 3 1028 1032 10.1016/j.athoracsur.2005.03.094 16122479
9. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. EM Langenfeld SE Calvano F Abou-Nukta SF Lowry P Amenta J Langenfeld, Carcinogenesis 2003 24 9 1445 1454 10.1093/carcin/bgg100 12819188
10. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. EM Langenfeld J Langenfeld, Mol Cancer Res 2004 2 3 141 149 15037653
11. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. EM Langenfeld Y Kong J Langenfeld, Oncogene 2006 25 5 685 692 10.1038/sj.onc.1209110 16247476
12. Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells. T Kumagai K Tomari T Shimizu K Takeda, Int J Mol Med 2006 17 2 285 291 16391828
13. Effects of bone morphogenetic protein-2 on human tumor cell growth and differentiation: a preliminary report. H Orui S Imaizumi T Ogino T Motoyama, J Orthop Sci 2000 5 6 600 604 10.1007/s007760070012 11180925
14. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. LG Horvath SM Henshall JG Kench JJ Turner D Golovsky PC Brenner GF O'Neill R Kooner PD Stricker JJ Grygiel,, et al. Prostate 2004 59 3 234 242 10.1002/pros.10361 15042598
15. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. JC Hardwick GR Van Den Brink SA Bleuming I Ballester JM Van Den Brande JJ Keller GJ Offerhaus SJ Van Deventer MP Peppelenbosch, Gastroenterology 2004 126 1 111 121 10.1053/j.gastro.2003.10.067 14699493
16. Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. H Soda E Raymond S Sharma R Lawrence C Cerna L Gomez GA Timony DD Von Hoff E Izbicka, Anticancer Drugs 1998 9 4 327 331 10.1097/00001813-199804000-00006 9635923
17. Bone: formation by autoinduction. MR Urist, Science 1965 150 698 893 899 10.1126/science.150.3698.893 5319761
18. Novel regulators of bone formation: molecular clones and activities. JM Wozney V Rosen AJ Celeste LM Mitsock MJ Whitters RW Kriz RM Hewick EA Wang, Science 1988 242 4885 1528 1534 10.1126/science.3201241 3201241
19. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. KA Waite C Eng, Hum Mol Genet 2003 12 6 679 684 10.1093/hmg/12.6.679 12620973
20. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. XZ Wen S Miyake Y Akiyama Y Yuasa, Biochem Biophys Res Commun 2004 316 1 100 106 10.1016/j.bbrc.2004.02.016 15003517
21. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. BT Feeley L Krenek N Liu WK Hsu SC Gamradt EM Schwarz J Huard JR Lieberman, Bone 2006 38 2 154 166 10.1016/j.bone.2005.07.015 16126463
22. Bone morphogenetic protein-2 and type IV collagen expression in psammoma body forming ovarian cancer. Y Kiyozuka H Nakagawa H Senzaki Y Uemura S Adachi Y Teramoto T Matsuyama K Bessho A Tsubura, Anticancer Res 2001 21 3B 1723 1730 11497252
23. Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. C Le Page V Ouellet J Madore F Ren TJ Hudson PN Tonin DM Provencher AM Mes-Masson, Br J Cancer 2006 94 3 436 445 10.1038/sj.bjc.6602933 16421595